UNSPSC 51111620: Acadesine

This classification denotes a purine antagonist with the molecular formula C9H14N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53IEF47846, chemically known as 1h-imidazole-4-carboxamide, 5-amino-1-beta-d-ribofuranosyl- but generally known as acadesine, which bears US NIH Compound Identifier 17513. Acadesine most often appears in base and phosphate form. European Medicines Agency schedules Acadesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07365MIG.

I cannot write a substantive summary from this source. The source provides only a UNSPSC code (51111620) and a chemical name (Acadesine), with no record of recent state and local procurement opportunities, issuing bodies, geographic activity, or scope information. Without the <most-recent-state-local-contract-opportunities> block or supporting procurement context, I cannot characterize what state and local governments actually buy under this code, which jurisdictions solicit it, or whether pursuing activity under it is warranted.

To produce a decision-relevant summary, I would need recent RFP, RFQ, IFB, or ITB notices showing actual procurement activity under this code, along with issuing-body names, response dates, and scope details.